ADGRB1 and neoplasm: Liu et al. showed that decreased expression of BAI1 is correlated with poor prognosis in lung cancer, while overexpression of BAI1 inhibited tumor growth by inducing metabolic reprogramming via the SCD1-HMGCR module [33].